Outcome of Board Meeting

INDGN/SE/2026-27/63 29 October 2026 BSE Limited, National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai- 400001, India. Mumbai – 400 051, India. Scrip Code: 544172 Trading symbol: INDGN Dear Sir / Madam, Subject: Outcome of Board Meeting held on October 29, 2026 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that the Board of Directors of Indegene Limited at its meeting held on Thursday, October 29, 2026, has, inter alia: 1. Approved unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Auditors thereon for the 2nd quarter and half year ended September 30, 2026. The Financial Results along with the Limited Review Report of the Auditors with an unmodified opinion and CFO declaration are enclosed herewith as Annexure – A. 2. Approved allotment under RSU Scheme 2020 and ESOP Scheme 2020. The detailed particulars required under Regulation 30 of the Listing Regulations read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided in Annexure - B. 3. Noted and accepted the resignation tendered by Mr. Mark Francis Dzialga (DIN: 00955485) from the position of Non-Executive - Non-Independent Director of the Company, with effect from close of business hours of October 29, 2026. The Board placed on record its appreciation for the valuable guidance, support and services rendered by Mr. Mark Francis Dzialga during his association with the Company. A copy of the resignation letter is enclosed herewith as Annexure - C. 4. Noted the re-constitution of the Nomination and Remuneration Committee and Investment Committee consequent to the cessation of membership of Mr. Mark Francis Dzialga from both the Committees. The composition of the reconstituted committees is provided in Annexure – D. 5. Noted and accepted the resignation tendered by Ms. Srishti Ramesh Kaushik (M. No.: A21609) on October 29, 2026, from the position of Company Secretary, Compliance Officer and Key Managerial Personnel of the Company. The Board placed on record its appreciation for the services and contributions rendered by Ms. Srishti Ramesh Kaushik during her tenure as Company Secretary of the Company and will be relieved from her duties with effect from the close of business hours on December 02, 2026. A copy of the resignation letter is enclosed herewith as Annexure – E. The detailed particulars required under Regulation 30 of the Listing Regulations read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided in Annexure - F. Indegene Limited Third Floor, Aspen G-4 Block, Manyata Embassy Business Park (SEZ), Outer Ring Road, Nagawara, Bengaluru- 560 045, Karnataka, India Phone: +91 80 4674 4567, +91 80 4644 7777 compliance.officer@indegene.com www.indegene.com CIN: L73100KA1998PLC102040 6. Approved amendment to the Prevention of Sexual Harassment Policy of the Company. Please be informed that pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the securities of the Company by its Designated Persons shall reopen with effect from Monday, 02nd November, 2026. The meeting of the Board of Directors commenced at 06:30 PM (IST) and concluded at 07:16 PM (IST). The above information will be made available on the website of the Company: https://www.indegene.com/ We request you to kindly take the same on record. Thanking You Yours Sincerely, For Indegene Limited Srishti Ramesh Kaushik Company Secretary and Compliance Officer Encl: A/a Annexure A Chartered Accountants Prestige Trade Tower, Level 19 46, Palace Road, High Grounds, Bengaluru – 560 001 Karnataka, India Tel: +91 (80) 6188 6000 Fax: +91 (80) 6188 6011 INDEPENDENT AUDITOR’S REVIEW REPORT ON REVIEW OF INTERIM CONSOLIDATED FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF INDEGENE LIMITED 1. We have reviewed the accompanying Statement of Consolidated Unaudited Financial Results of INDEGENE LIMITED (“the Parent”) and its subsidiaries (the Parent and its subsidiaries together referred to as “the Group”), for the quarter and six months ended September 30, 2026 (“the Statement”) being submitted by the Parent pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“the Listing Regulations”). 2. This Statement, which is the responsibility of the Parent’s Management and approved by the Parent’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of Parent’s personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. The Statement includes the results of the entities as mentioned in Annexure I to this review report. 5. Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. Page 1 of 3 6. The consolidated unaudited financial results includes the interim financial information of 1 subsidiary and 10 step down subsidiaries which have not been reviewed by their auditors, whose interim financial information reflects total assets of Rs 906 million as at September 30 2026, total revenue of Rs. 385 million and Rs 798 million for the quarter and six months ended September 30, 2026 respectively, total loss after tax of Rs. 47 million and Rs. 59 million for the quarter and six months ended September 30, 2026 respectively, and other comprehensive income/(loss) of Rs. 17 million and Rs. (1) million for the quarter and six months ended September 30, 2026 respectively, as considered in the Statement. According to the information and explanations given to us by the Management, these interim financial information are not material to the Group. Our Conclusion on the Statement is not modified in respect of our reliance on the interim financial information certified by the Management. For Deloitte Haskins & Sells Chartered Accountants Firm’s Registration No. 008072S Sathya P Koushik Partner Membership No.: 206920 UDIN: 26206920 [Showing first 8,000 characters — download PDF for full document]